Christopher Scott Hill - 31 Dec 2022 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role
SVP & CFO
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol
CLB
Transactions as of
31 Dec 2022
Transactions value $
-$252,767
Form type
4
Filing time
04 Jan 2023, 15:55:50 UTC
Previous filing
17 Feb 2022
Next filing
21 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Tax liability -$252,766 -12,470 -20% $20.27* 50,172 31 Dec 2022 Direct
transaction CLB Common Shares Options Exercise $0 +31,688 +102% $0 62,642 31 Dec 2022 Direct
holding CLB Common Shares 59 31 Dec 2022 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Options Exercise $0 -31,688 -100% $0* 0 31 Dec 2022 Common Shares 31,688 $0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.